论文部分内容阅读
目的评价肠易激综合征(IBS)中西医结合临床路径应用于临床的实际效果。方法采用同期队列研究,将83例IBS患者分为路径组41例和非路径组42例,路径组患者在治疗指南的基础上,建立IBS中西医结合临床路径;非路径组患者按常规治疗。比较两组患者中医症状积分、平均住院天数和平均住院总费用。结果两组患者治疗后腹痛、腹胀、腹泻、便秘症状积分与治疗前比较均明显降低(P<0.05或P<0.01);路径组腹胀积分治疗前后差值与非路径组比较,差异有统计学意义(P<0.05)。路径组患者平均住院天数为(5.88±2.38)天,非路径组为(6.83±2.88)天,两组比较差异无统计学意义(P>0.05)。路径组平均住院总费用(5609.32±1863.17)元,明显低于非路径组的(6616.33±2440.68)元(P<0.05)。结论 IBS中西医结合临床路径可有效改善患者临床症状、减少平均住院总费用。
Objective To evaluate the clinical effect of integrated traditional Chinese and western medicine on irritable bowel syndrome (IBS) in clinical practice. Methods According to the cohort study, 83 IBS patients were divided into pathological group and non-pathologic group, 41 cases and 42 non-pathological group. The pathological group was established on the basis of the treatment guideline, and the IBS integrated traditional and western medicine clinical pathology was established. TCM symptom score, average hospitalization days and average hospitalization costs were compared between the two groups. Results The scores of abdominal pain, abdominal distension, diarrhea and constipation in both groups were significantly lower than those before treatment (P <0.05 or P <0.01). There was significant difference between before and after treatment Significance (P <0.05). The average length of hospital stay was (5.88 ± 2.38) days in the path group and (6.83 ± 2.88) days in the non-path group, with no significant difference between the two groups (P> 0.05). The average hospitalization cost of the path group (5609.32 ± 1863.17) yuan was significantly lower than that of the non-pathological group (6616.33 ± 2440.68) yuan (P <0.05). Conclusion IBS clinical pathways of Integrative Medicine can effectively improve the clinical symptoms and reduce the average cost of hospitalization.